Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine

NCT00602784 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Valneva Austria GmbH